Axxam is constantly evolving and developing new approaches and concepts to address the salient challenges presented by modern day discovery research. We have invested a significant proportion of our resources into the development of innovative technologies and tools for enabling the discovery process to successfully overcome the many challenges faced by life sciences companies.
Our group of highly-skilled scientists experienced in generating new tools for cell-based assays for HTS, merge their various scientific expertises - from molecular biology and cell biology to biochemistry and electrophysiology - to develop solutions for the major issues and bottlenecks of the drug discovery process.
Axxam has built a strong IP Portfolio of technologies and applications, which are applied to our services activities and discovery programs. Our patent portfolio includes new technologies and tools for High Throughput Screening, detection methods and primary and stem cells for discovery, as described below.
Please select from the following links to learn more about each technology and its applications:
- Novel Photoproteins: calcium-binding bioluminescent photoproteins
- FlashLight: secreted luciferase reporter system for intact live cell analysis
- chAMPion: innovative luminescence-based universal GPCR and Ca2+ channel reporter cells
- GFP: novel monomeric green fluorescent proteins
- PhotoStem: stem cells for HTS (neuron like cells)
- PhotoTopo®: luminescent transgenic mice
Axxam welcomes enquiries about accessing our portfolio of discovery enabling technologies. We are committed to inventing tomorrow’s enabling discovery tools to provide solutions for today’s most important discovery needs.
Please, contact us to find out more about the opportunities for licensing Axxam’s proprietary technologies.
|
